Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease-Reference-Cited by-同舟云学术

Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker for Transmural Inflammation in Crohn's Disease

Published:2022-12-23 Issue: Volume:Publish Ahead of Print Page:
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Takenaka Kento,Kitazume Yoshio,Kawamoto Ami,Fujii Toshimitsu,Udagawa Yumi,Wanatabe Ryosuke,Shimizu Hiromichi,Hibiya Shuji,Nagahori Masakazu,Ohtsuka Kazuo,Sato Hiroyuki,Hirakawa Akihiro,Watanabe Mamoru,Okamoto Ryuichi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference22 articles.

1. STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD;Turner;Gastroenterology,2021

2. Small bowel healing detected by endoscopy in patients with Crohn's disease after treatment with antibodies against tumor necrosis factor;Takenaka;Clin Gastroenterol Hepatol,2020

3. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn's disease;Takenaka;Gastroenterology,2014

4. Development and validation of a simplified magnetic resonance index of activity for Crohn's disease;Ordás;Gastroenterology,2019

5. Relevance of monitoring transmural disease activity in patients with Crohn's disease: Current status and future perspectives;Wilkens;Therap Adv Gastroenterol,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission;Intestinal Research;2024-08-19

2. Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission;Intestinal Research;2024-08-19

3. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers;Biomedicines;2024-07-08

4. Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis;Journal of Clinical Medicine;2024-05-17

5. Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn’s disease small bowel lesion in capsule endoscopy;Intestinal Research;2024-05-07